Pathology: mBC - TNBC - L1 - all population;
mBC - TNBC - L1 - all population | ||||
IMpassion-130 (all population), 2018 | IMpassion-131 (all population), 2020 | KEYNOTE-355 (all population), 2020 | ||
atezolizumab plus paclitaxel | 1 | T1 | ||
pembrolizumab plus SoC | 1 | T1 | ||
atezolizumab plus nab-paclitaxel | 1 | T1 | ||
placebo plus SoC | 0 | T0 | ||
Standard of Care (SoC) | 0 | T0 | T0 |